ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

20 links0 made here, not in the record41 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02299999SAFIR02_Breast - Efficacyof Genome Analysis as aTherapeutic Decision Toolfor Patients WithMetastatic Breast CancerUNICANCERPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSVistusertibEntry “AZD2014”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAZD4547Intervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCapivasertibEntry “AZD5363”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAZD 8931Entry “AZD8931”, read by our name rule›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAZD 6244Entry “Selumetinib”, read by our name…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundVandetanibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBicalutamideIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundOlaparibIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedAnthracyclinesIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorTaxoidsEntry “Taxanes”, read by our name rule›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCyclophosphamideIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCapecitabineEntry “DNA intercalators”, read by ou…›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorMethotrexateIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorINT008408Entry “vinca alkaloids”, read by our …›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorPlatinum CompoundsEntry “Platinum based chemotherapies”…›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorMitomycinEntry “Mitomycin C”, read by our name…›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorEribulinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorDurvalumabEntry “MEDI4736”, read by our name ru…›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Vistusertib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “AZD2014”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3VistusertibClaude Opus 5.5TestedCurrent
Nov 3AZD4547Claude Opus 5.5TestedCurrent
Nov 3CapivasertibClaude Opus 5.5TestedReplaced
Nov 3AZD 8931Claude Opus 5.5TestedCurrent
Nov 3AZD 6244Claude Opus 5.5BackgroundCurrent
Nov 3VandetanibClaude Opus 5.5BackgroundCurrent
Nov 3BicalutamideClaude Opus 5.5BackgroundCurrent
Nov 3OlaparibClaude Opus 5.5BackgroundReplaced
Nov 3AnthracyclinesClaude Opus 5.5ComparatorCurrent
Nov 3TaxoidsClaude Opus 5.5ComparatorCurrent
Nov 3CyclophosphamideClaude Opus 5.5ComparatorCurrent
Nov 3CapecitabineClaude Opus 5.5ComparatorCurrent
Nov 3MethotrexateClaude Opus 5.5ComparatorCurrent
Nov 3INT008408Claude Opus 5.5ComparatorCurrent
Nov 3Platinum CompoundsClaude Opus 5.5ComparatorCurrent
Nov 3BevacizumabClaude Opus 5.5ComparatorCurrent
Nov 3MitomycinClaude Opus 5.5ComparatorCurrent
Nov 3EribulinClaude Opus 5.5ComparatorCurrent
Nov 3DurvalumabClaude Opus 5.5TestedCurrent
Nov 3CapivasertibClaude Opus 5.5TestedCurrent
Nov 3OlaparibClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18VistusertibRule based · role ruleTestedAgrees
Nov 18AZD4547Rule based · role ruleTestedAgrees
Nov 18CapivasertibRule based · role ruleTestedAgrees
Nov 18AZD 8931Rule based · role ruleTestedAgrees
Nov 18AZD 6244Rule based · role ruleBackgroundAgrees
Nov 18VandetanibRule based · role ruleBackgroundAgrees
Nov 18BicalutamideRule based · role ruleBackgroundAgrees
Nov 18OlaparibRule based · role ruleBackgroundOverridden
Nov 18AnthracyclinesRule based · role ruleComparatorAgrees
Nov 18TaxoidsRule based · role ruleComparatorAgrees
Nov 18CyclophosphamideRule based · role ruleComparatorAgrees
Nov 18CapecitabineRule based · role ruleComparatorAgrees
Nov 18MethotrexateRule based · role ruleComparatorAgrees
Nov 18INT008408Rule based · role ruleComparatorAgrees
Nov 18Platinum CompoundsRule based · role ruleComparatorAgrees
Nov 18BevacizumabRule based · role ruleComparatorAgrees
Nov 18MitomycinRule based · role ruleComparatorAgrees
Nov 18EribulinRule based · role ruleComparatorAgrees
Nov 18DurvalumabRule based · role ruleTestedAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.